Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules

Journal of Immunology

Volumn 164, Issue 2, 2000, Pages 805-811

  Jun, Youngsoo ^a   Kim, Eunok ^a   Jin, Mirim ^a   Sung, Ha Chin ^a   Han, Boon ^b   Geraghty, Daniel E ^c   Ahn, Kwangseog ^a  

^a Korea University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FETUS WASTAGE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOPATHOGENESIS; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; TROPHOBLAST; VIRUS GENE;

EID: 0034650691     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.2.805     Document Type: Article

References (40)

1. Cross, J. C., Z. Werb, and S. J. Fisher. 1994. Implantation and the placenta: key pieces of the development puzzle. Science 266:1508.
2. Chumbley, G., A. King, N. Holmes, and Y. W. Loke. 1993. In situ hybridization and northern blot demonstration of HLA-G mRNA in human trophoblast populations by locus-specific oligonucleotide. Hum. Immunol. 37:17.
3. Ellis, S. A., M. S. Palmer, and A. J. McMichael. 1990. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J. Immunol. 144:731.
4. King, A., C. Boocock, A. M. Sharkey, L. Gardner, A. Beretta, A. G. Siccardi, and Y. W. Loke. 1996. Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 156:2068.
5. Munz, C., N. Holmes, A. King, Y. W. Loke, M. Colonna, H. Schild, and H.-G. Rammensee. 1997. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med. 185:385.
6. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189:1093.
7. Pazmany, L., O. Mandelboirn, M. Vales-Gomez, D. M. Davis, H. T. Reyburn, and J. L. Strominger. 1996. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274:792.
8. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90:12000.
9. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7:739.
10. Ho, M. 1991. Cytomegalovirus: Biology and Infection. Plenum Medical Book Company, New York.
11. Altshuler, G. 1974. Immunologic competence of the immature human fetus: morphologic evidence from intrauterine cytomegalovirus infection. Obstet. Gynecol. 43:811.
12. Kriel, R. L., G. A. Gates, H. Wulff, N. Powell, J. D. Poland, and T. D. Chin. 1970. Cytomegalovirus isolations associated with pregnancy wastage. Am. J. Obstet. Gynecol. 106:885.
13. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248.
14. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769.
15. Wiertz, E. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones. T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432.
16. Ahn, K., A. Angulo, P. Ghazal, P. A. Peterson, Y. Yang, and K. Fruh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93:10990.
17. Jones, T. R., E. J. Wiertz, L. Sun, K. N. Fish, J. A. Nelson, and H. L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93:11327.
18. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones. E. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613.
19. Hengel, H., J. O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G. J. Hammerling, U. H. Koszinowski, and F. Momburg. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623.
20. Lehner, P. J., J. T. Karttunen, G. W. Wilkinson, and P. Cresswell. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94:6904.
21. Ellis, S. A., T. Strachan, M. S. Palmer, and A. J. McMichael. 1989. Complete nucleotide sequence of a unique HLA class I C locus product expressed on the human choriocarcinoma cell line BeWo. J. Immunol. 142:3281.
22. Lee, N., A. R. Malacko, A. Ishitani, M.-C. Chen, J. Bajorath, H. Marquardt, and D. E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591.
23. Schust, D. J., D. Tortorella, J. Seebach, C. Phan, and H. L. Ploegh. 1998. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188:497.
24. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415.
25. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline- responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547.
26. Cox, J. H., J. W. Yewdell, L. C. Eisenlohr, P. R. Johnson, and J. R. Bennink. 1990. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247:715.
27. Andersson, M., S. Paabo, T. Nilsson, and P. A. Peterson. 1985. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215.
28. Jones, T. R., L. K. Hanson, L. Sun, J. S. Slater, R. S. Stenberg, and A. E. Campbell. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:4830.
29. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411.
30. Sernee, M., H. Ploegh, and D. J. Schust. 1998. Why certain antibodies cross-react with HLA-A and HLA-G: Epitope mapping of two common MHC class I reagents. Mol. Immunol. 35:177.
31. Rosenthal, L. J., P. J. Panitz, D. B. Crutchfield, and J. Y. Chou. 1981. Cytomegalovirus replication in primary and passaged human placental cells. Intervirology 16:168.
32. Hughes, E. A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94:1896.
33. Neefjes, J. J., F. Momburg, and G. J. Hammerling. 1993, Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769.
34. Schust, D. J., A. B. Hill, and H. L. Ploegh. 1996. Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J. Immunol. 157:3375.
35. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboirn, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661.
36. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152:3862.
37. κ major histocompatibility complex class I protein on the cell surface after infection of murine cells by Pseudorabies virus. J. Virol. 73:5748.
38. Machold, R. P., E. J. Wiertz, T. R. Jones, and H. L. Ploegh. 1997. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J. Exp. Med. 185:363.
39. Lee, N., D. Goodlett, A. Ishitani, H. Marquardt, and D. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol 160:4951.
40. Hosken, N. A., and M. J. Bevan. 1992. An endogenous antigenic peptide by-passes the class I antigen presentation defect in RMA-S. J. Exp. Med. 175:719.